• 1. III Safety evaluation of natural and synthetic flavourings
  K. R. Butterworth Chem. Soc. Rev. 1978 7 185

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters

Butanoic acid, 3-methyl-, 2-propen-1-yl ester (CAS No. 2835-39-4): A Comprehensive Overview in Modern Chemical and Pharmaceutical Research

Butanoic acid, 3-methyl-, 2-propen-1-yl ester, identified by its Chemical Abstracts Service (CAS) number 2835-39-4, is a significant compound in the realm of organic chemistry and pharmaceutical applications. This ester, derived from butanoic acid and 2-propen-1-ol, exhibits unique structural and functional properties that make it a subject of considerable interest in both academic research and industrial development. The compound's molecular structure, characterized by a butyl chain and an ester group linked to an allyl moiety, imparts distinct reactivity and potential utility in various chemical syntheses.

The CAS No. 2835-39-4 of this compound serves as a unique identifier, ensuring precise referencing in scientific literature, patents, and regulatory filings. This specificity is crucial in the chemical and pharmaceutical industries, where exactness in compound identification is paramount for reproducibility and safety. The Butanoic acid, 3-methyl-, 2-propen-1-yl ester structure combines the acuity of butanoic derivatives with the versatility of allylic systems, making it a valuable intermediate in organic synthesis.

In recent years, the Butanoic acid, 3-methyl-, 2-propen-1-yl ester has garnered attention for its potential applications in pharmaceutical research. Its chemical profile suggests suitability as a precursor in the synthesis of more complex molecules. For instance, researchers have explored its utility in the preparation of bioactive compounds that mimic natural signaling molecules or serve as scaffolds for drug development. The ester functionality allows for further derivatization, enabling chemists to tailor properties such as solubility, bioavailability, and metabolic stability.

One of the most compelling aspects of Butanoic acid, 3-methyl-, 2-propen-1-yl ester is its role in exploring novel synthetic pathways. The compound's allylic position provides a site for selective reactions, including additions and eliminations that can be harnessed to construct diverse molecular architectures. This flexibility has been exploited in the development of novel methodologies for constructing carbon-carbon bonds, which are essential in many pharmacophores. The CAS No. 2835-39-4 ensures that researchers worldwide can reliably obtain and utilize this compound for their studies.

Advances in computational chemistry have further enhanced the understanding of Butanoic acid, 3-methyl-, 2-propen-1-yl ester's reactivity. Molecular modeling studies have predicted its behavior in various reaction conditions, allowing for optimized synthetic strategies before experimental trials. These predictions are particularly valuable in drug discovery pipelines, where efficiency and cost-effectiveness are critical. The integration of experimental data with computational insights has led to more streamlined approaches for incorporating this ester into complex synthetic schemes.

The pharmaceutical industry has shown particular interest in Butanoic acid, 3-methyl-, 2-propen-1-yl ester due to its potential as an intermediate in the synthesis of therapeutic agents. Its structural motifs are reminiscent of certain bioactive compounds known for their antimicrobial, anti-inflammatory, or even anticancer properties. While not yet approved for any specific medical use, preliminary studies suggest that derivatives of this compound may exhibit promising biological activities. These findings have spurred further investigation into its pharmacological potential.

From an environmental perspective, the sustainability of using Butanoic acid, 3-methyl-, 2-propen-1-yl ester as a building block is also noteworthy. The compound can be synthesized from renewable feedstocks through biocatalytic processes, aligning with global efforts to reduce reliance on petrochemical resources. Such green chemistry approaches not only mitigate environmental impact but also enhance the economic viability of pharmaceutical production. The CAS No. 2835-39-4 facilitates tracking the sourcing and synthesis methods of this compound across different manufacturers.

In conclusion, Butanoic acid, 3-methyl-, 2-propen-1-yl ester (CAS No. 2835-39-4) represents a fascinating intersection of structural complexity and functional versatility. Its applications span from academic research to industrial synthesis, with particular relevance in pharmaceutical development. As our understanding of chemical reactivity continues to evolve through interdisciplinary collaboration—combining organic chemistry with computational modeling—this compound is poised to play an increasingly important role in shaping future advancements.

• 7493-69-8(Butyric acid, 2-ethyl-, allyl ester (8CI))
• 925-16-6(Diallyl Succinate)
• 7493-68-7(Allyl cyclohexanevalerate)
• 7493-65-4(ALLYL CYCLOHEXANEBUTYRATE)
• 2705-87-5(Allyl 3-cyclohexylpropanoate)
• 4728-82-9(Cyclohexaneacetic acid,2-propen-1-yl ester)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)